Jeffrey DeanUnless you’re actively scrubbing the co2, that’s what happens when you recirculate air.
James FalkA carbonator?
Michael Taylor shared a link.
Category: biotech/medical – Page 1157
A new drug therapy for breast cancer helped stop tumors from growing for twice as long as traditional chemotherapy, adding months to patients’ lives.
New artificial skin for bionic arm or AI robot | breakthrough photonic chip processes 2 billion images per second without memory device.
AI news includes new artificial skin to let AI robot, bionic arm or prosthetic limb feel with extreme touch sensitivity. New photonic chip allows AI to process and classify 2 billion images per second without needing storage device.
AI News Timestamps:
Several years ago, a promising therapeutic using stem cell factor (SCF) emerged that could potentially treat a variety of ailments, such as ischemia, heart attack, stroke and radiation exposure. However, during clinical trials, numerous patients suffered severe allergic reactions and development of SCF-based therapeutics stopped.
A research team led by engineers at The University of Texas at Austin has developed a related therapeutic that they say avoids these major allergic reactions while maintaining its therapeutic activity. The keys to the discovery, published recently in Nature Communications, were the use of a similar, membrane-bound version of SCF delivered in engineered lipid nanocarriers.
“We envision this as something you can inject where you have lack of blood flow and it could induce blood vessels to grow in that area,” said Aaron Baker, a professor in the Cockrell School of Engineering’s Department of Biomedical Engineering, and one of the leaders on the project.
Inara’s Trans Surgery Fund
Posted in biotech/medical, sex
In celebration of Pride Month, Inara, one of our moderators, is fundraising to pay for her transition surgery. I donated.
Gender dysphoria is the term used to describe a sense of discomfort or distress that a person may experience because of a mismatch between their gender identity and their sex assigned at birth. Methods of relieving gender dysphoria include transitioning socially (pronoun usage, name change, etc.) and physically (surgery).
I have medical insurance but it does not cover trans healthcare. Yes, we are still fighting for trans rights! I need allies willing to take action on my behalf.
In this bold new future, we have discovered the best possible use for artificial intelligence: making more pigs.
To assess whether a compound holds promise for treating a disease, researchers usually begin by studying its use in animals. This allows us to see if the compound has a chance of curing the disease.
Animal models, however, rarely reproduce all aspects of a disease. The alternative is to represent the disease in cell cultures. While at first glance, Petri dishes look quite different from a person with a disease, the reality could be quite different when you look at them more closely.
Alzheimer’s has been cured more than 400 times in laboratories. How then can we still consider Alzheimer’s to be incurable? The reason is that it has only been cured in animals.
A new colorectal cancer drug has shocked researchers with how effective it is against the highly dangerous disease, after it virtually cured every member of a clinical trial.
Dostarlimab, a monoclonal antibody drug that is already approved to treat endometrial cancer in the UK, smashed expectations in a trial at Memorial Sloan Kettering Cancer Center in New York.
One year after the trial ended, each of the 18 participants’ cancer had gone into remission, with doctors unable to find signs of the cancer in their body.
Sascha Roth remembers the phone call came on a hectic Friday evening.
She was racing around her home in Washington, D.C., to pack for New York, where she was scheduled to undergo weeks of radiation therapy for rectal cancer. But the phone call from Memorial Sloan Kettering Cancer Center (MSK) medical oncologist Andrea Cercek changed everything, leaving Sascha “stunned and ecstatic — I was so happy.”
Dr. Cercek told Sascha, then 38, that her latest tests showed no evidence of cancer, after Sascha had undergone six months of treatment as the first patient in a clinical trial involving immunotherapy at MSK.
